HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nifedipine therapy for coronary vasospasm.

Abstract
In conclusion, we observed first that nifedipine is highly efficacious in preventing the coronary vasospasm of Prinzmetal's variant angina. Secondly, nifedipine appears to be efficacious in preventing episodes of recurrent rest angina following an acute myocardial infarction. Although coronary vasospasm has not been clearly documented in patients with recurrent rest angina after infarction, a primary decrease in coronary blood flow is the most likely cause of this syndrome since the ischemia occurs at rest, at a time when myocardial oxygen demands are not elevated. In this highly unstable group of patients with coronary disease nifedipine may eliminate the need for bypass surgery or may provide clinical stability prior to more elective cardiac catheterization and surgery.
AuthorsP H Stone, E M Antman, J E Muller
JournalArchives des maladies du coeur et des vaisseaux (Arch Mal Coeur Vaiss) Vol. 76 Spec No Pg. 137-42 (Feb 1983) ISSN: 0003-9683 [Print] France
PMID6407436 (Publication Type: Journal Article)
Chemical References
  • Pyridines
  • Nifedipine
Topics
  • Angina Pectoris (etiology)
  • Angina Pectoris, Variant (complications, drug therapy)
  • Coronary Disease (complications, drug therapy)
  • Coronary Vasospasm (drug therapy, etiology)
  • Female
  • Humans
  • Male
  • Middle Aged
  • Myocardial Infarction (complications)
  • Nifedipine (administration & dosage, therapeutic use)
  • Pyridines (therapeutic use)
  • Recurrence

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: